NOTE

- EARNINGS PER COMMON SHARE

The following table presents the amounts used to compute basic and diluted earnings per common share, as well as the effect of dilutive potential common shares on weighted average shares outstanding (in thousands, except per share data):

	Three Months Ended					Nine Months Ended
	March 31					March 31
	2019			2018		2019			2018

BASIC EARNINGS PER SHARE

Net (loss) income	$	(3,168	)	$	220	$	(17,201	)	$	(16,877	)

Weighted average shares outstanding during the period, net of treasury shares (a)		25,893			25,581		25,828			25,546
Weighted average vested restricted stock units outstanding		33			49		40			44
Weighted average shares outstanding in the Deferred Compensation Plan during the period		206			245		215			245
Weighted average shares outstanding		26,132			25,875		26,083			25,835

Basic (loss) earnings per share	$	(0.12	)	$	0.01	$	(0.66	)	$	(0.65	)

DILUTED EARNINGS PER SHARE

Net (loss) income	$	(3,168	)	$	220	$	(17,201	)	$	(16,877	)

Weighted average shares outstanding
Basic		26,132			25,875		26,083			25,835

Effect of dilutive securities (b):
Impact of common shares to be issued under stock option plans, and contingently issuable shares, if any		--			562		--			--

Weighted average shares outstanding (c)		26,132			26,437		26,083			25,835

Diluted (loss) earnings per share	$	(0.12	)	$	0.01	$	(0.66	)	$	(0.65	)

(a)

Includes shares accounted for like treasury stock.

(b)

Calculated using the “Treasury Stock” method as if dilutive securities were exercised and the funds were used to purchase common shares at the average market price during the period.

(c)

Options to purchase

3,787,519

common shares and

1,945,348

common shares for the

three

months ended

March 31, 2019

and

2018,

respectively, were

not

included in the computation of the

three

month diluted loss per share because the exercise price was greater than the average fair market value of the common shares. Additionally, options to purchase

3,702,031

common shares and

3,086,121

common shares for the

nine

months ended at

March

31,

2019

and

2018,

respectively, were

not

included in the computation of the

nine

month diluted loss per share because the exercise price was greater than the average fair market value of the common shares. For the

three

months ended in

March 31, 2019

and the

nine

months ended

March 31, 2019

and

2018,

the effect of dilutive securities was

not

included in the calculation of diluted loss per share because there was a net loss for the period.